Glenmark Pharma tanks 5% on patent infringement lawsuit; FDA nod goes in vain
Meanwhile, the company today announced that Glenmark Pharmaceuticals. Inc, has been granted final approval by the US Food and Drug Administration (USFDA) for Clotrimazole and Betamethasone Dipropionate Cream USP, 1% | 0.05%, the therapeutic equivalent of Lotrisone Cream USP, 1% | 0.05% of Merck, Sharp and Dohme Corporation